Amanta Healthcare IPO Shines on Day 1 with 22% Grey Market Premium 🚀
What Happened Today 📅
Amanta Healthcare kicked off its ₹126 crore mainboard IPO today, September 1, 2025, with a price band of ₹120–₹126 per share. The minimum lot size is 119 shares, requiring an investment of approximately ₹14,994 at the upper band. Early grey market trends at 9:15 a.m. showed a premium of ₹28 per share, hinting at a potential listing price around ₹154—a 22% gain over the ₹126 upper band. The IPO is set to list on BSE and NSE next week, with allotment expected later this week.
Key IPO Details 📊
This book-built issue is a fresh issuance of 1 crore shares, totaling ₹126 crore. The allocation splits as follows: up to 50% for Qualified Institutional Buyers (QIBs), 15% for Non-Institutional Investors (NIIs), and 35% for retail investors. Amanta raised ₹37.8 crore from anchor investors pre-IPO, signaling strong early demand. Broker notes praise the company’s focus on capacity expansion for sterile parenterals and its regulatory reach, though some flag the valuation as steep at the upper band.
Grey Market Premium and Implied Gains 📈
On Day 1, the grey market premium (GMP) ranged between ₹28–₹30, suggesting a listing price of ₹154–₹156 at the upper band—a potential 22–23% gain. However, GMP is speculative and can shift based on subscription trends, market sentiment, and news. Investors should use it as a sentiment gauge alongside fundamentals and subscription data.
GMP Trend 📉
GMP rose from ₹21 to ₹28, signaling a ~22% upside vs. ₹126 issue price.
Business Snapshot 🏭
Amanta Healthcare specializes in sterile liquid pharmaceuticals, including large and small volume parenterals, ophthalmics, respiratory care, and irrigation solutions. Leveraging ABFS and ISBM technologies (SteriPort and ABFS platforms), the company distributes to over 300 domestic partners and exports to Africa, Latin America, the UK, and beyond. Its Hariyala, Gujarat facility supports multiple production lines for LVPs and SVPs, backed by regulatory certifications across various markets.
Financial and Valuation Context 💰
At the upper band, Amanta’s FY25 post-issue valuation is around 47x earnings, which some analysts consider fully priced compared to peers. However, the company’s revenue of ₹270–₹280 crore and improving profitability in FY25 position it for growth. IPO proceeds will fund SteriPort line expansion, new SVP capacity, and general corporate purposes, aligning with its sterile-focused growth strategy.
Case Study: GMP-Driven Listing Outcomes 📖
A recent healthcare IPO with a similar mid-20s GMP saw strong subscription and listed close to its projected premium. However, post-listing, the stock dipped as traders locked in gains, later stabilizing with strong quarterly results. For Amanta, listing gains may follow GMP trends, but long-term returns will depend on capex execution, export growth, and regulatory milestones.
Evaluating a Day 1 Bid 💡
An investor bidding for one lot at ₹126 could see a listing gain of ~₹3,332 (₹28 per share × 119 shares) if the GMP holds. Risks include GMP volatility, market swings, and the high valuation. A prudent approach involves monitoring subscription trends, anchor interest, and disclosures, using GMP as a guide, not a guarantee.
Data Table: Offer and GMP Overview 📋
| Metric | Detail |
|---|---|
| Issue size | ₹126 crore fresh issue |
| Price band | ₹120–₹126 per share |
| Lot size | 119 shares; min outlay ~₹14,994 at ₹126 |
| IPO dates | Sep 1–3, 2025 (subscription window) |
| Tentative listing | Sep 9, 2025 (BSE, NSE) |
| Anchor raised | ~₹37.8 crore pre-IPO |
| Day 1 GMP | ₹28–₹30; ~22–23% implied upside vs ₹126 |
| Recent GMP prints | Trend rising from ₹21 to ~₹28 into Day 1 |
Bottom Line 🔍
Amanta Healthcare’s IPO shows strong Day 1 momentum with a 22% GMP, but its valuation is considered full. Short-term investors should track subscription trends and market conditions, while long-term investors may focus on the company’s sterile portfolio growth and export potential. GMP is a useful signal but not a sure bet—stay vigilant! 🕵️
Frequently Asked Questions ❓
What is the latest Amanta Healthcare GMP on Day 1?
As of Day 1 morning, informal quotes indicate a GMP of about ₹28 per share, roughly 22% above the ₹126 upper band, though this may fluctuate intraday and throughout the offer.
What are the Amanta Healthcare IPO dates, lot size, and price band?
The IPO is open from September 1–3, 2025, with a lot size of 119 shares and a price band of ₹120–₹126 per share.
When and where is Amanta Healthcare expected to list?
The tentative listing date is September 9, 2025, on BSE and NSE, following the post-closure schedule.
How will Amanta Healthcare use the IPO proceeds?
Funds will support the expansion of SteriPort manufacturing lines, new SVP capacity, and general corporate purposes to drive growth in sterile products.
Is the Amanta Healthcare IPO considered fully priced?
Analyst notes suggest a valuation of ~47x FY25 earnings at the upper band, seen as full despite strong prospects in sterile pharmaceuticals and exports.
🌐 Explore More on Global Market Today
Dive deeper into the latest updates, insights, and expert analysis across our most popular categories. Stay informed on business, economy, AI, and more – all in one place.
